UNCY
Unicycive Therapeutics, Inc.Company with tickers: UNCY
CIK
1766140
CUSIP
90466Y202
Shares Outstanding
25,237,782
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-08-25 | Aggarwal Gaurav | Director | Other | 3,199 |
| 2025-08-25 | Aggarwal Gaurav | Director | Other | 652,900 |
| 2025-07-28 | Laumas Sandeep | CFO and CBO | Award | 21,200 |
| 2025-07-28 | Townsend John | Chief Financial Officer | Award | 10,000 |
| 2025-07-28 | Aggarwal Gaurav | Director | Award | 21,200 |
| 2025-07-28 | Kenkare-Mitra Sara | Director | Award | 21,200 |
| 2025-07-28 | Gupta Shalabh K. | Director, CEO | Award | 325,000 |
| 2025-07-28 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 90,000 |
| 2025-07-28 | Jermasek Douglas | EVP of Corporate Strategy | Award | 10,000 |
| 2025-02-18 | Aggarwal Gaurav | Director | Other | 1,400,000 |
| 2025-02-18 | Aggarwal Gaurav | Director | Other | 686 |
| 2024-10-09 | Aggarwal Gaurav | Director | Other | 2,695 |
| 2024-10-09 | Aggarwal Gaurav | Director | Other | 5,500,000 |
| 2024-08-12 | Townsend John | Chief Financial Officer | Award | 40,256 |
| 2024-08-12 | Gupta Shalabh K. | Director, CEO | Award | 232,868 |
| 2024-08-12 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 81,750 |
| 2024-08-12 | Jermasek Douglas | EVP of Corporate Strategy | Award | 81,750 |
| 2024-04-15 | Townsend John | Chief Financial Officer | Award | 228,119 |
| 2024-04-15 | Gupta Shalabh K. | Director, CEO | Award | 1,319,583 |
| 2024-04-15 | Jermasek Douglas | EVP of Corporate Strategy | Award | 463,250 |
| 2024-04-15 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 463,250 |
| 2023-09-05 | Laumas Sandeep | CFO and CBO | Award | 189,236 |
| 2023-09-05 | Aggarwal Gaurav | Director | Award | 180,000 |
| 2023-09-05 | Kenkare-Mitra Sara | Director | Award | 180,000 |
| 2023-09-05 | Ryan John L | Director | Award | 112,147 |
| 2023-09-05 | Kenkare-Mitra Sara | Director | Other | 0 |
| 2023-08-28 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 1,355,000 |
| 2023-08-28 | Jermasek Douglas | EVP of Corporate Strategy | Award | 1,355,000 |
| 2023-08-28 | Gupta Shalabh K. | Director, CEO | Award | 4,684,775 |
| 2023-08-28 | Townsend John | Chief Financial Officer | Award | 570,329 |
| 2023-07-11 | Aggarwal Gaurav | Director | Other | 18,621,655 |
| 2023-07-11 | Aggarwal Gaurav | Director | Other | 8,077 |
| 2023-07-11 | Aggarwal Gaurav | Director | Other | 12,802,388 |
| 2023-07-11 | Aggarwal Gaurav | Director | Other | 13,429,000 |
| 2023-07-11 | Aggarwal Gaurav | Director | Other | 3,470,152 |
| 2023-07-11 | Aggarwal Gaurav | Director | Other | 11,638,534 |
| 2023-07-11 | Jermasek Douglas | EVP of Corporate Strategy | Convert | 104,612 |
| 2023-07-11 | Jermasek Douglas | EVP of Corporate Strategy | Convert | 50 |
| 2023-07-11 | Jermasek Douglas | EVP of Corporate Strategy | Convert | 72,047 |
| 2023-07-11 | Jermasek Douglas | EVP of Corporate Strategy | Convert | 79,252 |
| 2023-07-11 | Gupta Pramod | EVP, Pharmaceuticals and BD | Convert | 31,700 |
| 2023-07-11 | Gupta Pramod | EVP, Pharmaceuticals and BD | Convert | 41,845 |
| 2023-07-11 | Gupta Pramod | EVP, Pharmaceuticals and BD | Convert | 28,818 |
| 2023-07-11 | Gupta Pramod | EVP, Pharmaceuticals and BD | Convert | 20 |
| 2023-07-11 | Gupta Shalabh K. | Director, CEO | Convert | 50 |
| 2023-07-11 | Gupta Shalabh K. | Director, CEO | Convert | 72,047 |
| 2023-07-11 | Gupta Shalabh K. | Director, CEO | Convert | 104,612 |
| 2023-07-11 | Gupta Shalabh K. | Director, CEO | Convert | 79,252 |
| 2023-03-08 | Aggarwal Gaurav | Director | Other | 0 |
| 2023-03-08 | Aggarwal Gaurav | Director | Award | 8,077 |
| 2023-03-08 | Gupta Shalabh K. | Director, CEO | Award | 50 |
| 2023-03-08 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 20 |
| 2023-03-08 | Jermasek Douglas | EVP of Corporate Strategy | Award | 50 |
| 2022-11-21 | Gupta Shalabh K. | Director, CEO | Award | 86,000 |
| 2022-11-21 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 28,000 |
| 2022-11-21 | Townsend John | Chief Financial Officer | Award | 35,000 |
| 2022-11-21 | Jermasek Douglas | EVP of Corporate Strategy | Award | 55,000 |
| 2022-11-18 | Jermasek Douglas | EVP of Corporate Strategy | Other | 0 |
| 2022-11-18 | Jermasek Douglas | EVP of Corporate Strategy | Other | 70,400 |
| 2022-07-15 | Schiller Brigitte | Director | Convert | 26,738 |
| 2022-07-15 | Schiller Brigitte | Director | Convert | 26,738 |
| 2022-05-16 | Schiller Brigitte | Director | Buy | 15,000 |
| 2021-07-15 | Gupta Shalabh K. | Director, CEO | Award | 116,279 |
| 2021-07-15 | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | 34,884 |
| 2021-07-15 | Townsend John | Chief Financial Officer | Award | 18,605 |
| 2021-07-12 | Ryan John L | Director | Other | 0 |
| 2021-07-12 | Ryan John L | Director | Other | 58,140 |
| 2021-07-12 | Townsend John | Chief Financial Officer | Other | 0 |
| 2021-07-12 | Gupta Shalabh K. | Director, CEO | Other | 0 |
| 2021-07-12 | Gupta Shalabh K. | Director, CEO | Other | 2,321,092 |
| 2021-07-12 | Schiller Brigitte | Director | Other | 0 |
| 2021-07-12 | Laumas Sandeep | CFO and CBO | Other | 0 |
| 2021-07-12 | Laumas Sandeep | CFO and CBO | Other | 48,838 |
| 2021-07-12 | Gupta Pramod | EVP, Pharmaceuticals and BD | Other | 0 |